WEC
48
2
NTAP
73
6
GLW
71
2
COP
42
-3
DD
67
11
FFIV
58
2
MU
55
4
SWKS
42
5
FRT
58
-5
IR
71
-12
SPG
55
5
FOXA
38
3
GWW
48
4
NFLX
59
-2
HIG
72
2
BAC
50
2
AXP
71
-2
AAP
33
4
WBA
28
4
NVDA
63
4
WEC
48
2
NTAP
73
6
GLW
71
2
COP
42
-3
DD
67
11
FFIV
58
2
MU
55
4
SWKS
42
5
FRT
58
-5
IR
71
-12
SPG
55
5
FOXA
38
3
GWW
48
4
NFLX
59
-2
HIG
72
2
BAC
50
2
AXP
71
-2
AAP
33
4
WBA
28
4
NVDA
63
4
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
12

BIO.B
Bio-Rad Laboratories

Last Price:
274.55
Seasonality Move:
3.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO.B News And Ratings

See the #1 stock for the next 7 days that we like better than BIO.B

BIO.B Financial Statistics

Sales & Book Value

Annual Sales: $2.67B
Cash Flow: $38.8M
Price / Cash Flow: 37.55
Annual Sales: $306.51
Price / Book: 0.91

Profitability

EPS (TTM): -21.49000
Net Income (TTM): $-637.32M
Gross Margin: $1.43B
Return on Equity: -7.08%
Return on Assets: -5.03%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO.B is 53.42%.
  • The Selling, General & Administrative Expenses for BIO.B have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO.B is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO.B
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 5.83
Quick Ratio: 4.01

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIO.B Technical Analysis vs Fundamental Analysis

Sell
12
Bio-Rad Laboratories (BIO.B) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?